IL2RG and acute myeloid leukemia: The introduction of a deletion of the interleukin 2 (IL2) receptor gamma chain (Il2rγ) gene led to an even more immune compromised mouse model, the NOD-scid Il2rγnull (NSG) mouse, that improved engraftment of patient AML cells regardless of the French-American-British classification or cytogenetic features (176).